Chen discussant at ASTRO Annual Meeting plenary session

Ronald C. Chen, MD, MPH, a UNC Lineberger member and associate professor in the UNC School of Medicine Department of Radiation Oncology, was a discussant in the plenary session of the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO) on Sept. 26.

Chen discussant at ASTRO Annual Meeting plenary session click to enlarge Ronald C. Chen, MD, MPH, is a UNC Lineberger member and associate professor in the UNC School of Medicine Department of Radiation Oncology.

At the meeting in Boston, Chen was invited to discuss results of a randomized, phase III trial during the meeting's plenary session. The trial compared traditional radiation treatment for prostate cancer delivered across eight weeks to hypofractionated radiation delivered across five and a half weeks for men with early stage, low-risk prostate cancer. The trial showed that shortened radiation was equally effective, and had no worse quality of life outcomes, Chen said.

"These results have major significance clinically, and now makes shortened radiation a standard option for prostate cancer treatment," Chen said.

The annual meeting was held in Boston Sept. 25-28. 

For more information, click here